Jump to main content
Jump to site search

Issue 19, 2021

An efficient strategy for cancer therapy using a tumor- and lysosome-targeted organic photothermal agent

Author affiliations

Abstract

A dual-targeted organic photothermal agent for tumor cells and lysosomes was developed. In vitro and in vivo experiments demonstrated that it possessed low cytotoxicity, good biological compatibility, and tumor inhibitory effects.

Graphical abstract: An efficient strategy for cancer therapy using a tumor- and lysosome-targeted organic photothermal agent

Supplementary files

Article information


Submitted
10 Mar 2021
Accepted
27 Apr 2021
First published
30 Apr 2021

Nanoscale, 2021,13, 8790-8794
Article type
Communication

An efficient strategy for cancer therapy using a tumor- and lysosome-targeted organic photothermal agent

H. Wang, H. Zhang, Y. Xiang, W. Pan, N. Li and B. Tang, Nanoscale, 2021, 13, 8790 DOI: 10.1039/D1NR01547H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.


Social activity

Search articles by author

Spotlight

Advertisements